SIGMAR1 and cancer: Conversely, targeting SIGMAR1 inhibits ferroptosis in cancer cells and mitigates cisplatin-induced acute kidney injury in mice through pharmacological means (using CGI1746 and BD1063) or genetic interventions [144].